HeartBeam (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common ...

Now CE Marked, the Kardia 12L ECG System leverages AI to detect 35 cardiac determinations, simplifying the ECG process and expediting access to critical heart data AliveCor's Kardia 12L launches in ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing ...

AliveCor announced today that it has received CE mark in Europe for its Kardia 12L electrocardiogram (ECG) system.

AliveCor’s Kardia 12L, a pocket-sized AI ECG system, has received CE Mark for launch in France, Germany, Italy, Spain, and ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

These are the most basic ECG devices. They are generally used for monitoring the heart, checking for arrhythmias, etc. Nowadays, the portable and wearable health monitoring devices also include ...

HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...